Agbede OO, Adeyemi OO and Olatinwo AWO , 2011. Sero-Prevalence of Antenatal Rubella in UITH. Opn Pub Heal. 4, 10-16.
Adam O, Makkawi T, Kannan A. Seroprevalence of rubella among pregnant women in Khartoum state , Sudan. East Medit Heal J , 19 :812-15.
Chiang Lin C, Yuh Yang C and Tang Shih C ,2010 . Rubella Seroepidemiology and Catch-up Immunization among Pregnant Women in Taiwan: Comparison between Women Born in Taiwan and Immigrants from Six Countries in Asia. Am J Trop Med Hyg. 82,40-4.
Chantler S, Evans CJ and Mortimer PP ,1982. A comparison of antibody capture radio and enzyme immunoassays with immunofluorescence for detecting IgM antibody in infants with congenital rubella. J Viro Meth . 4,305-13.
Centers for Disease Control .Control and prevention of rubella, 2001 . evaluation and management of suspected outbreaks. rubella in pregnant women , and surveillance for congenital rubella syndrome. MMWR Recomm Rep. 50, 1–23.
Esteghamati A , Gouya MM and Zahraei SM, 2007. Progress in measles and rubella elimination in Iran. Pediatr Infect Dis J . 26, 1137–41.
El Sayed N , Kandeel N and Barakat I, 2011. Progress Toward Measles and Rubella Elimination in Egypt. J Inf Dis. 204,318–24.
Hussein N, Jaffery GH and Hasnain SH ,2006. Seroprevalence of Rubella IgG and IgM antibodies in infants suspected of having Rubella infection .
Biomedica . 22 ,25-3.
Honarvar B ,Moghadami M, and Moattari A , 2013. Seroprevalence of Anti-Rubella and Anti-Measles IgG Antibodies in Pregnant Women in Shiraz, Southern Iran: Outcomes of a Nationwide Measles-Rubella Mass Vaccination Campaign. PLOS ONE. 8,1-8.
Hamkar R, Jalilvand S and Mokhtari-Azad T, ,2006. Evaluation of immunity against rubella in Iranian after mass campaign for measles-rubella vaccination on December 2003 . Am J Infect Control . 34, 588–92.
Halperin SA , Ferrera G and Scheifele D ,2009 . Safety and immunogenicity of a measles-mumps-rubellavaricella vaccine given as a second dose in children
up to six years of age. Vaccine . 27,2701-06.
Mahmoodi M and Vahedi E, 2007. Comparison of rubella immunity of Mashhad’s women before and after Measles–Rubella mass campaigns 2003–2005 .Med J Mash Uni Med Sci . 50,177–86 .
Namaei M, Ziaee M and Naseh N , 2008. Congenital rubella syndrome in infants of women vaccinated during or just before pregnancy with measles-rubella vaccine. Indian J Med Res . 127 ,551-54.
Obijimi TO , Ajetomobi AB and Sule WF,2013. Prevalence of Rubella virus Specific immunoglobulin G and M in pregnant women attending two tertiary hospitals in southwestern NIGERIA . Afr J Clin Exper Mic. 14,134-9.
Ouyahia A, Segueni A and Laouamri S , ,2013.
Seroprevalence of rubella among women of childbearing age in Algeria. Is there a need for a rubella vaccination. Int J Pub Heal Epi . 2,56-9.
Pourabbas B, Ziyaeyan M and Alborzi A ,2008. Efficacy of measles and rubella
vaccination one year after the nationwide campaign in Shiraz, Iran .Int J Infect Dis. 12,43–46.
Raut SK , Kulkarni PS and Phadke MA , 2007. Persistence of Antibodies Induced by Measles-MumpsRubella Vaccine in Children in India. Clin Vac Immunol. 14 ,1370–71.
Shamsizadeh A , Nikfar R and Makvandi M ,2012. Seroprevalence Measles , Mumps and Rubella antibodies in 18 months and 6.5 years old children :
Six monthes after Measles , Mumps and Rubella (MMR) vaccination. Joundishapour microbial. 4, 578-81.
Van Loon AM, van der Logt JThM and vanderVeen J, 1981. Enzyme-linked immunosorbent assay for measurement of antibody against cytomegalovirus and rubella virus in a single serum dilution. J Clin Pathol . 34,665-69.
Vauloup-Fellous C, Grangeot-Keros L,2007. Humoral Immune Response after Primary Rubella Virus Infection and after Vaccination. Clin Vac Immunol . 14,
World Health Organization. WHO/IVB Database.2006 and the World Population Prospects : the 2004 Revision.
World Health Organization. WHO Vaccine-Preventable Diseases : Monitoring System 2008 Global Summary.Available at <http://www.who.int/immunization/documents/en/.
World Health Organization ,1991. Rubella and congenital rubella syndrome in